- New Challenges of Safety Monitoring of Rock Slopes: The Third Wave2008 | Faculty of Science
- Proposed MRI Safety Monitoring of Patients with Multiple Sclerosis Treated with Natalizumab2016 | First Faculty of Medicine
- Therapy in rheumatology: biological therapy, corticosteroids, therapy of osteoporosis. Side effect and principals of safety monitoring2004 | First Faculty of Medicine
- The European Cystic Fibrosis Society-Clinical Trials Network: an international network to optimize clinical research for a rare disease2013 | Second Faculty of Medicine
- Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic2020 | First Faculty of Medicine
- Current recommendations for the use of MR in multiple sclerosis in clinical practice2023 | First Faculty of Medicine
- Rapid and straightforward electrochemical approach for the determination of the toxic food azo dye tartrazine using sensors based on silver solid amalgam2023 | Faculty of Science
- Treatment of dyslipidemias - questionaires, and the future2016 | First Faculty of Medicine
- Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosis2019 | First Faculty of Medicine
- Diverse pharmacovigilance jurisdiction-The right way for global drug safety?2023 | Third Faculty of Medicine
- A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer2012 | Third Faculty of Medicine
- R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes2014 | First Faculty of Medicine
- Pregnancy Experience : Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program2016 | First Faculty of Medicine
- Understanding the positive benefit: risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program2017 | First Faculty of Medicine, Second Faculty of Medicine
- Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment2021 | First Faculty of Medicine
- The disease-specific clinical trial network for primary ciliary dyskinesia: PCD-CTN2022 | Second Faculty of Medicine
- Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis: a pilot, randomised, sham-controlled trial2022 | Central Library of Charles University, Faculty of Physical Education and Sport
- Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery2019 | First Faculty of Medicine
- Apixaban in Patients with Atrial Fibrillation2011 | Publication without faculty affiliation
- Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer2017 | Faculty of Medicine in Hradec Králové
- Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial2022 | First Faculty of Medicine, Central Library of Charles University, Faculty of Mathematics and Physics